DIA Oligonucleotide-Based Therapeutics Conference 2024	Closed
	DIA/FDA Oligonucleotide-Based Therapeutics Conference 10/28/2024 - 10/30/2024 Venue: Capital Hilton, Washington DC, United States
Please note ! All dates are subject to changes.

The DIA Oligonucleotide-Based Therapeutics Conference brings together leading experts to inform, educate, and share advancements in oligonucleotide-based therapeutic product development. Developed collaboratively by regulators, industry professionals, and academics, the program covers a wide range of topics from the nonclinical, CMC, and clinical areas. The conference offers a unique experience with multiple perspectives presented, and the opportunity to interface with regulators from around the globe. Website: https://www.diaglobal.org/en/conference-listing

Venues
	Capital Hilton
	1001 16th St NW, Washington, District of Columbia 20036, Washington DC United States Tel: +1-202-393-1000 http://hilton.com

Organizers
	DIA - Drug Information Association
	21 Dupont Circle NW Suite 300 Washington, DC 20036, Washington DC United States Tel: +1-202-601.8900 https://www.diaglobal.org/

PC Version	About Us
Showseye - Global Professional Events